BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahdi AF, Malacrida B, Nolan J, McCumiskey ME, Merrigan AB, Lal A, Tormey S, Lowery AJ, McGourty K, Kiely PA. Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers. Cells 2020;9:E1582. [PMID: 32629869 DOI: 10.3390/cells9071582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ma L, Chen Z, Feng M, Liu Q, Sun Y, Wang W, Zhang J, Zhang H, Liang Y, Liu J. A diverse treatment with the extract of Euphorbia fischeriana Steud. and Ziziphus jujuba Mill. for breast cancer nude mice of MCF-7 (ER+) cells or MDA-MB-453 (ER-) cells via modulation of the PI3k/Akt signalling pathway. Pharmacological Research - Modern Chinese Medicine 2022. [DOI: 10.1016/j.prmcm.2022.100198] [Reference Citation Analysis]
2 Prieto-fernández L, Menéndez ST, Otero-rosales M, Montoro-jiménez I, Hermida-prado F, García-pedrero JM, Álvarez-teijeiro S. Pathobiological functions and clinical implications of annexin dysregulation in human cancers. Front Cell Dev Biol 2022;10:1009908. [DOI: 10.3389/fcell.2022.1009908] [Reference Citation Analysis]
3 He Y, Pei Y, Liu K, Liu L, Tian Y, Li H, Cong M, Liu T, Ma H, You H, Jia J, Zhang D, Wang P. GITR/GITRL reverse signalling modulates the proliferation of hepatic progenitor cells by recruiting ANXA2 to phosphorylate ERK1/2 and Akt. Cell Death Dis 2022;13:297. [DOI: 10.1038/s41419-022-04759-z] [Reference Citation Analysis]
4 Lainetti PF, Leis-Filho AF, Kobayashi PE, de Camargo LS, Laufer-Amorim R, Fonseca-Alves CE, Souza FF. Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro. Molecules 2021;26:1213. [PMID: 33668689 DOI: 10.3390/molecules26051213] [Reference Citation Analysis]
5 Gibbs LD, Mansheim K, Maji S, Nandy R, Lewis CM, Vishwanatha JK, Chaudhary P. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients. Cancers (Basel) 2020;13:E2. [PMID: 33374917 DOI: 10.3390/cancers13010002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhou Y, Lih TM, Pan J, Höti N, Dong M, Cao L, Hu Y, Cho KC, Chen SY, Eguez RV, Gabrielson E, Chan DW, Zhang H, Li QK. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. J Hematol Oncol 2020;13:170. [PMID: 33287876 DOI: 10.1186/s13045-020-01013-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Rescher U, Gerke V, Lim LHK, Jaiswal JK. Special Issue "Recent Developments in Annexin Biology". Cells 2020;9:E2477. [PMID: 33202541 DOI: 10.3390/cells9112477] [Reference Citation Analysis]